Monday, January 31, 2022

Fact check: Comirnaty, Pfizer's FDA-approved vaccine, available in US

The FDA authorized Pfizer's coronavirus vaccine for emergency use in December. Eight months later, the agency fully approved the shot for most Americans.

The authorization changed, but the vaccine didn't. Comirnaty is simply the brand name for Pfizer's shot.

"The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty ... for the prevention of COVID-19 disease in individuals 16 years of age and older," the FDA wrote in an Aug. 23 press release about the shot's approval.

No comments:

Post a Comment